Markus Bergauer
8Patents
6h-index
19Co-inventors
52Inventor score
Filing activity: Oct 6, 2006 → Jan 4, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7655693B2 | Compounds | Human Necessities | 12 | Active |
| US7855218B2 | Compounds | Chemistry; Metallurgy | 11 | Active |
| US8153681B2 | Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamide | Human Necessities | 9 | Active |
| US8153623B2 | Compounds | Chemistry; Metallurgy | 9 | Active |
| US7803833B2 | Compounds | Chemistry; Metallurgy | 8 | Active |
| US8143306B2 | Methods of treating bipolar disorders | Human Necessities | 8 | Active |
| US7732600B2 | Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors | Chemistry; Metallurgy | 0 | Active |
| US7592346B2 | Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.